Beta-lactam hypersensitivity in children: Frequency and risk factors

被引:2
|
作者
Ben Romdhane, Haifa [1 ]
Ben Fredj, Nadia [1 ]
Ben Fadhel, Najah [1 ]
Chadli, Zohra [1 ]
Abderrahmen, Ahlem [1 ]
Boughattas, Naceur A. [1 ]
Chaabane, Amel [1 ]
Aouam, Karim [1 ]
机构
[1] Univ Monastir, Dept Pharmacol, EPS Fattouma Bourguiba, Fac Med, Monastir, Tunisia
关键词
hypersensitivity; β ‐ lactams; children; skin tests; oral provocation test; risk factors; DRUG ALLERGY; SKIN-TESTS; DIAGNOSTIC EVALUATION; CLINICAL HISTORY; ANTIBIOTICS; CHALLENGE; PROVOCATION;
D O I
10.1111/bcp.14647
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To determine the frequency of an authentic beta-lactam (BL) hypersensitivity (HS) amongst a large number of children and to identify clinical risk factors that predict this hypersensitivity. Methods All children with suspected BL allergy were evaluated by skin tests (ST) with the suspected BL. A 1-day oral provocation test (OPT) was performed in children with negative ST. We defined an authentic BL-HS case if the child exhibited a positive ST or a positive OPT. Risk factors associated with BL-HS were assessed using a univariate analysis. Covariates showing a P-value <.2 were included in the multivariate logistic regression analysis to determine independent predictors. Results A total of 354 patients reporting 368 suspected BL reactions were included. The diagnosis of BL-HS was established in 24 children (6.7%). All these children had a positive ST. OPT was performed in 30 patients and was negative in all of them. In 110 children with a negative ST, BL was tolerated. In the risk factors analysis, 164 children were included. Older age (>5 years) at the reaction (odds ratio = 1.11; 95% confidence interval, 1.01-1.22; P = .02) and BL administered (odds ratio = 7.7; 95% confidence interval, 2.76-21.8; P < .001) were significantly associated with authentic BL-HS. Conclusion BL-HS should be evaluated with an appropriate allergy work-up before strict prohibition is made. In addition, age of patient and BL involved can be used as predictive factors of developing BL-HS in this population.
引用
收藏
页码:150 / 157
页数:8
相关论文
共 50 条
  • [1] Allergy to beta-lactam antibiotics in children: Risk factors for a positive diagnostic work-up
    Dias de Castro, E.
    Carolino, F.
    Carneiro-Leao, L.
    Barbosa, J.
    Ribeiro, L.
    Cernadas, J. R.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (05) : 417 - 423
  • [2] Approach for delabeling beta-lactam allergy in children
    Maria, R. Saenz de Santa
    Bogas, G.
    Labella, M.
    Ariza, A.
    Salas, M.
    Dona, I.
    Torres, M. J.
    FRONTIERS IN ALLERGY, 2023, 4
  • [3] Penicillin and Beta-Lactam Hypersensitivity
    Har, Daniel
    Solensky, Roland
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (04) : 643 - +
  • [4] Risk stratification in beta-lactam allergy
    Arikoglu, Tugba
    Kont, Aylin Ozhan
    Demirhan, Ali
    Yuksek, Burcu Caglar
    Tokmeci, Nazan
    Kuyucu, Semanur
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2021, 8 (04) : 285 - 297
  • [5] Hypersensitivity reactions to beta-lactam antibiotics
    Amsler, E.
    Soria, A.
    REVUE DE MEDECINE INTERNE, 2017, 38 (11): : 737 - 748
  • [6] Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children
    Zambonino, Maria A.
    Luis Corzo, Jose
    Munoz, Candelaria
    Requena, Gloria
    Ariza, Adriana
    Mayorga, Cristobalina
    Urda, Antonio
    Blanca, Miguel
    Torres, M. J.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2014, 25 (01) : 80 - 87
  • [7] A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children
    Demirhan, Ali
    Yildirim, Didem D.
    Arikoglu, Tugba
    Ozhan, Aylin K.
    Tokmeci, Nazan
    Yuksek, Burcu C.
    Kuyucu, Semanur
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (06) : E159 - E166
  • [8] Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity
    Goh, Si Hui
    Chong, Kok Wee
    Chiang, Wen Chin
    Goh, Anne
    Loh, Wenyin
    ASIA PACIFIC ALLERGY, 2021, 11 (01)
  • [9] Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome*
    Van der Heggen, Tatjana
    Dhont, Evelyn
    Willems, Jef
    Herck, Ingrid
    Delanghe, Joris R.
    Stove, Veronique
    Verstraete, Alain G.
    Vanhaesebrouck, Sophie
    De Paepe, Peter
    De Cock, Pieter A. J. G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (07) : E309 - E318
  • [10] Role of clinical history in beta-lactam hypersensitivity
    Plager, Jessica
    Judd, Allen
    Blumenthal, Kimberly
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (04) : 320 - 326